✦ LIBER ✦

Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: To lump or split?

✍ Scribed by Luc Laberge; Yves Dauvilliers; Paul Bégin; Louis Richer; Stéphane Jean; Jean Mathieu

Book ID: 116793888
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 261 KB
Volume: 19
Category: Article
ISSN: 0960-8966
DOI: 10.1016/j.nmd.2009.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fatigue and daytime sleepiness scale in

Fatigue and daytime sleepiness scale in myotonic dystrophy type 1

✍ Hermans, Mieke C.E.; Merkies, Ingemar S.J.; Laberge, Luc; Blom, Eveline W.; Tenn 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

P5.3 Fatigue and daytime sleepiness scal

P5.3 Fatigue and daytime sleepiness scale in myotonic dystrophy type 1

✍ M.C.E. Hermans; I.S.J. Merkies; L. Laberge; E.W. Blom; E.K. Vanhoutte; A. Tennan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Cortical damage in brains of patients wi

Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities

✍ Antonio Giorgio; Maria T. Dotti; Marco Battaglini; Silvia Marino; Marzia Mortill 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 231 KB

Efficacy and Tolerability of a 20-mg Dos

Efficacy and Tolerability of a 20-mg Dose of Methylphenidate for the Treatment of Daytime Sleepiness in Adult Patients With Myotonic Dystrophy Type 1: A 2-Center, Randomized, Double-Blind, Placebo-Controlled, 3-Week Crossover Trial

✍ Jack Puymirat; Jean-Pierre Bouchard; Jean Mathieu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Creatine monohydrate supplementation doe

Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1

✍ Mark Tarnopolsky; Douglas Mahoney; Terry Thompson; Heather Naylor; Timothy J. Do 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

## Abstract Creatine monohydrate (CrM) supplementation may increase strength in some types of muscular dystrophy. A recent study in myotonic muscular dystrophy type 1 (DM1) did not find a significant treatment effect, but measurements of muscle phosphocreatine (PCr) were not performed. We completed